vs
HERITAGE COMMERCE CORP（HTBK）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是HERITAGE COMMERCE CORP的1.3倍（$69.8M vs $53.6M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 28.2%，领先355.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 15.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 12.8%）
本文介绍的企业主体信息与内容描述不符，描述内容实际为美国商会，该商会成立于1912年4月23日，是美国规模最大的游说类商业协会 advocacy 团体，成立之初得益于时任总统威廉·霍华德·塔夫脱与劳工商务部长查尔斯·内格尔推动，旨在代表工商界发声。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
HTBK vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$53.6M
营收增速更快
RIGL
高出5.6%
15.6%
净利率更高
RIGL
高出355.8%
28.2%
两年增速更快
RIGL
近两年复合增速
12.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.6M | $69.8M |
| 净利润 | $15.1M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 41.0% | 33.2% |
| 净利率 | 28.2% | 384.0% |
| 营收同比 | 15.6% | 21.2% |
| 净利润同比 | 42.3% | 1769.2% |
| 每股收益（稀释后） | $0.25 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTBKRIGL
| Q4 25 | $53.6M | $69.8M | ||
| Q3 25 | $50.0M | $69.5M | ||
| Q2 25 | $47.8M | $101.7M | ||
| Q1 25 | $46.1M | $53.3M | ||
| Q4 24 | $46.4M | $57.6M | ||
| Q3 24 | $42.2M | $55.3M | ||
| Q2 24 | $41.7M | $36.8M | ||
| Q1 24 | $42.1M | $29.5M |
净利润HTBKRIGL
| Q4 25 | $15.1M | $268.1M | ||
| Q3 25 | $14.7M | $27.9M | ||
| Q2 25 | $6.4M | $59.6M | ||
| Q1 25 | $11.6M | $11.4M | ||
| Q4 24 | $10.6M | $14.3M | ||
| Q3 24 | $10.5M | $12.4M | ||
| Q2 24 | $9.2M | $-1.0M | ||
| Q1 24 | $10.2M | $-8.2M |
毛利率HTBKRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率HTBKRIGL
| Q4 25 | 41.0% | 33.2% | ||
| Q3 25 | 41.1% | 40.9% | ||
| Q2 25 | 18.7% | 60.1% | ||
| Q1 25 | 35.4% | 23.9% | ||
| Q4 24 | 31.8% | 28.9% | ||
| Q3 24 | 34.3% | 25.4% | ||
| Q2 24 | 31.3% | 1.2% | ||
| Q1 24 | 34.2% | -23.6% |
净利率HTBKRIGL
| Q4 25 | 28.2% | 384.0% | ||
| Q3 25 | 29.4% | 40.2% | ||
| Q2 25 | 13.4% | 58.6% | ||
| Q1 25 | 25.2% | 21.5% | ||
| Q4 24 | 22.9% | 24.9% | ||
| Q3 24 | 24.9% | 22.5% | ||
| Q2 24 | 22.1% | -2.8% | ||
| Q1 24 | 24.1% | -27.9% |
每股收益（稀释后）HTBKRIGL
| Q4 25 | $0.25 | $14.11 | ||
| Q3 25 | $0.24 | $1.46 | ||
| Q2 25 | $0.10 | $3.28 | ||
| Q1 25 | $0.19 | $0.63 | ||
| Q4 24 | $0.17 | $0.82 | ||
| Q3 24 | $0.17 | $0.70 | ||
| Q2 24 | $0.15 | $-0.06 | ||
| Q1 24 | $0.17 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $708.6M | $391.5M |
| 总资产 | $5.8B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资HTBKRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务HTBKRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益HTBKRIGL
| Q4 25 | $708.6M | $391.5M | ||
| Q3 25 | $700.0M | $117.6M | ||
| Q2 25 | $694.7M | $81.9M | ||
| Q1 25 | $696.2M | $18.6M | ||
| Q4 24 | $689.7M | $3.3M | ||
| Q3 24 | $685.4M | $-14.6M | ||
| Q2 24 | $679.2M | $-29.9M | ||
| Q1 24 | $676.3M | $-31.7M |
总资产HTBKRIGL
| Q4 25 | $5.8B | $513.6M | ||
| Q3 25 | $5.6B | $242.5M | ||
| Q2 25 | $5.5B | $206.7M | ||
| Q1 25 | $5.5B | $176.0M | ||
| Q4 24 | $5.6B | $164.0M | ||
| Q3 24 | $5.6B | $139.4M | ||
| Q2 24 | $5.3B | $128.4M | ||
| Q1 24 | $5.3B | $126.5M |
负债/权益比HTBKRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $61.3M | — |
| 自由现金流率自由现金流/营收 | 114.3% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | 4.08× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流HTBKRIGL
| Q4 25 | $61.7M | $22.0M | ||
| Q3 25 | $18.9M | $24.0M | ||
| Q2 25 | $8.0M | $30.5M | ||
| Q1 25 | $14.8M | $-893.0K | ||
| Q4 24 | $39.0M | $14.5M | ||
| Q3 24 | $5.3M | $21.7M | ||
| Q2 24 | $10.5M | $302.0K | ||
| Q1 24 | $7.3M | $-5.0M |
自由现金流HTBKRIGL
| Q4 25 | $61.3M | — | ||
| Q3 25 | $18.8M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $37.3M | — | ||
| Q3 24 | $4.9M | — | ||
| Q2 24 | $9.9M | — | ||
| Q1 24 | $6.9M | — |
自由现金流率HTBKRIGL
| Q4 25 | 114.3% | — | ||
| Q3 25 | 37.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 80.5% | — | ||
| Q3 24 | 11.6% | — | ||
| Q2 24 | 23.6% | — | ||
| Q1 24 | 16.4% | — |
资本支出强度HTBKRIGL
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 1.0% | — |
现金转化率HTBKRIGL
| Q4 25 | 4.08× | 0.08× | ||
| Q3 25 | 1.28× | 0.86× | ||
| Q2 25 | 1.25× | 0.51× | ||
| Q1 25 | 1.28× | -0.08× | ||
| Q4 24 | 3.67× | 1.01× | ||
| Q3 24 | 0.50× | 1.75× | ||
| Q2 24 | 1.14× | — | ||
| Q1 24 | 0.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
